Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Clinical trial NCT01464931 · COMPLETED
Trial details
- NCT number
- NCT01464931
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-01-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.